Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center

被引:93
作者
Lee, AJ
Boro, MS
Knapp, KK
Meier, JL
Korman, NE
机构
[1] Vet Adm Med Ctr, San Francisco, CA 94121 USA
[2] Univ Pacific, Sch Pharm & Hlth Sci, Stockton, CA 95211 USA
[3] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[4] UOP, Adjunct Fac, Sch Pharm & Hlth Sci, Des Plaines, IL 60017 USA
[5] Western Univ Hlth Sci, Ctr Pharm Practice & Res & Dev, Pomona, CA USA
关键词
Department of Veterans Affairs; economics; interventions; outcomes; pharmacists; hospital;
D O I
10.1093/ajhp/59.21.2070
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacist recommendations and their clinical and economic outcomes in a Veterans Affairs (VA) medical center were studied. The first 600 pharmacist recommendations that met study criteria were evaluated for type and frequency, rate of acceptance by physicians, potential benefit or harm, and economic consequences. The study site included inpatient and outpatient settings and a skilled-nursing facility. The most frequent types of pharmacist recommendations involved adjusting the dosage or frequency of administration and discontinuing a drug that was not indicated for the patient's medical problem. The rate of acceptance of the recommendations was 92%. The recommendations led to improved clinical outcomes in over 30% of cases in each setting and no change in over 40% of cases in each setting. Evaluators determined that patient harm was avoided by the recommendations in 90% of cases; patient harm was caused in less than 1% of cases. The overall mean cost, avoidance per recommendation was $700, and the mean total cost avoidance for all 600 recommendations was $420,155. Pharmacist recommendations improved clinical outcomes and saved money at a VA medical center.
引用
收藏
页码:2070 / 2077
页数:8
相关论文
共 31 条
[1]  
[Anonymous], 1998, Hosp Pharm
[2]  
BAYLIFF DC, 1990, CAN J HOSP PHARM, V43, P167
[3]   COST JUSTIFICATION OF CLINICAL PHARMACY SERVICES ON A GENERAL-SURGERY TEAM - FOCUS ON DIAGNOSIS-RELATED GROUP CASES [J].
BERTCH, KE ;
HATOUM, HT ;
WILLETT, MS ;
WITTE, KW .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (11) :906-911
[4]   EFFECT OF PHARMACISTS ON HEALTH-CARE OUTCOMES IN HOSPITALIZED-PATIENTS [J].
BJORNSON, DC ;
HINER, WO ;
POTYK, RP ;
NELSON, BA ;
LOMBARDO, FA ;
MORTON, TA ;
LARSON, LV ;
MARTIN, BP ;
SIKORA, RG ;
CAMMARATA, FA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (09) :1875-1884
[5]   PHARMACIST-MANAGED MEDICATION REVIEW IN A MANAGED CARE SYSTEM [J].
BORGSDORF, LR ;
MIANO, JS ;
KNAPP, KK .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (06) :772-777
[6]   4 YEARS EXPERIENCE WITH A CLINICAL INTERVENTION PROGRAM - COST AVOIDANCE AND IMPACT OF A CLINICAL COORDINATOR [J].
CATANIA, HF ;
YEE, WP ;
CATANIA, PN .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (12) :2701-2705
[7]   ECONOMIC CONSEQUENCES OF 2 DRUG-USE CONTROL-SYSTEMS IN A TEACHING HOSPITAL [J].
CLAPHAM, CE ;
HEPLER, CD ;
REINDERS, TP ;
LEHMAN, ME ;
PESKO, L .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (11) :2329-2340
[8]  
Committee on quality of health care in America-Institute of Medicine, 2001, CROSS QUAL CHASM NEW
[9]   Assessment of a community pharmacy-based program for patients with asthma [J].
Cordina, M ;
McElnay, JC ;
Hughes, CM .
PHARMACOTHERAPY, 2001, 21 (10) :1196-1203
[10]  
*DEP VET AFF OP, 1989, STAFF GUID PROD EN 9